AdvanSource Biomaterials Analysis
AdvanSource Biomaterials holds a debt-to-equity ratio of 0.061. With a high degree of financial leverage come high-interest payments, which usually reduce AdvanSource Biomaterials' Earnings Per Share (EPS).
Given that AdvanSource Biomaterials' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which AdvanSource Biomaterials is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of AdvanSource Biomaterials to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, AdvanSource Biomaterials is said to be less leveraged. If creditors hold a majority of AdvanSource Biomaterials' assets, the Company is said to be highly leveraged.
AdvanSource Biomaterials is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of AdvanSource Biomaterials pink sheet analysis is to determine its intrinsic value, which is an estimate of what AdvanSource Biomaterials is worth, separate from its market price. There are two main types of AdvanSource Biomaterials' stock analysis: fundamental analysis and technical analysis.
The AdvanSource Biomaterials pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and AdvanSource Biomaterials' ongoing operational relationships across important fundamental and technical indicators.
AdvanSource |
AdvanSource Pink Sheet Analysis Notes
About 90.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.52. AdvanSource Biomaterials last dividend was issued on the 14th of March 2022. The entity had 1:50 split on the 11th of March 2022. Previously, the company was engaged in the development of polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. EKIMAS Corporation was incorporated in 1993 and is based in Las Vegas, Nevada. Ekimas Corp is traded on OTC Exchange in the United States.The quote for AdvanSource Biomaterials is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on AdvanSource Biomaterials please contact Bennett Yankowitz at 424 256 8560 or go to http://www.advbiomaterials.com.AdvanSource Biomaterials Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. AdvanSource Biomaterials' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding AdvanSource Biomaterials or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| AdvanSource Biomaterials is not yet fully synchronised with the market data | |
| AdvanSource Biomaterials has some characteristics of a very speculative penny stock | |
| AdvanSource Biomaterials has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (287 K) with profit before overhead, payroll, taxes, and interest of 2.47 M. | |
| AdvanSource Biomaterials currently holds about 186 K in cash with (282 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 90.0% of the company shares are held by company insiders |
AdvanSource Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.12 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AdvanSource Biomaterials's market, we take the total number of its shares issued and multiply it by AdvanSource Biomaterials's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.AdvanSource Biomaterials Outstanding Bonds
AdvanSource Biomaterials issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. AdvanSource Biomaterials uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most AdvanSource bonds can be classified according to their maturity, which is the date when AdvanSource Biomaterials has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
AdvanSource Biomaterials Debt to Cash Allocation
The company has a current ratio of 10.23, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist AdvanSource Biomaterials until it has trouble settling it off, either with new capital or with free cash flow. So, AdvanSource Biomaterials' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AdvanSource Biomaterials sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AdvanSource to invest in growth at high rates of return. When we think about AdvanSource Biomaterials' use of debt, we should always consider it together with cash and equity.AdvanSource Biomaterials Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the AdvanSource Biomaterials' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of AdvanSource Biomaterials, which in turn will lower the firm's financial flexibility.AdvanSource Biomaterials Corporate Bonds Issued
Most AdvanSource bonds can be classified according to their maturity, which is the date when AdvanSource Biomaterials has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding AdvanSource Biomaterials to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in AdvanSource Pink Sheet
If you are still planning to invest in AdvanSource Biomaterials check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AdvanSource Biomaterials' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |